Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into

Yingzhi Chen1, Meng Zhang1, Hongyue Jin2

  • 1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai 201203, China; University of Chinese Academy of Sciences, 19A Yuquan Rd, Beijing 100049, China.

Biomaterials
|December 4, 2016
PubMed

Insights

This study introduces a novel prodrug system for protein toxins, overcoming PEGylation challenges in cancer therapy. The system enhances tumor targeting and cytoplasmic delivery, reducing side toxicity for improved cancer treatment.

Area of Science:

  • Biotechnology
  • Drug Delivery
  • Cancer Therapy

Background:

  • Poor tumor targeting and cytoplasmic delivery limit protein toxin efficacy in cancer therapy.
  • Polyethylene glycol (PEG)ylation improves drug circulation but hinders tumor cell interaction, creating a delivery challenge.
  • The 'PEG dilemma' necessitates strategies to maintain stealth circulation while enabling tumor-specific activation.

Purpose of the Study:

  • To develop a site-selectively PEGylated, gelatinase-triggered, cell-penetrating trichosanthin protein delivery system.
  • To create a prodrug feature for reduced toxicity and enhanced Enhanced Permeability and Retention (EPR) effect.
  • To engineer a gelatinase-activatable strategy for improved tumor targeting and cytoplasmic delivery.

Main Methods:

  • Inteintein-based ligation for site-specific protein toxin modification.
  • Construction of a macromolecular prodrug system via intein-mediated ligation synthesis.
  • On-column purification and cleavage for site-specific PEGylation via C-terminus conjugation.

Main Results:

  • Successfully developed a protocol for constructing a multifunctional prodrug system.
  • Achieved site-specific PEGylation, creating a PEG-capped, cell-penetrating trichosanthin system.
  • Incorporated a gelatinase-cleavable linker for tumor-specific activation of cytoplasmic delivery.

Conclusions:

  • The developed system addresses the PEG dilemma for enhanced protein drug delivery.
  • Provides a facile protocol for site-specific modification of protein drugs, improving druggability.
  • Offers a promising strategy for advanced cancer therapeutics with improved targeting and reduced side effects.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
71
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
7.2K